AzTrials
AzTrials

Arthroplasty Replacement, KneeCHUVeduc@homeNCT07345299

Development and Measurement of the Effects of a Digital Education Solution for Patients Undergoing Total Hip or Knee Arthroplasty

A study testing Digital Preoperative Education with CHUVeduc@home in people with Arthroplasty Replacement, Knee and Arthroplasty, Replacement, Hip, run by Haute Ecole de Santé Vaud at 1 site in Switzerland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of a digital patient education solution, CHUVeduc@home, in improving preoperative preparation for patients undergoing total hip or knee arthroplasty. In Switzerland, many patients receive joint replacements each year to relieve osteoarthritis-related pain. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Digital Preoperative Education with CHUVeduc@home
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteSwitzerland
Study dates
15 Feb 2026to 28 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • male and female patients admitted to the CHUV musculoskeletal department during the study period
  • primary total hip replacement or primary total knee replacement
  • a Risk Assessment and Prediction Tool (RAPT) score >6

Who cannot join

  • a RAPT score <6,
  • knee/hip arthroplasty revision surgery
  • inability to give informed consent or answer questionnaires knowledgeably due to language or cognitive impairment as reported in the medical record

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Claude Pichonnaz, Ph.D contact

+41213168126

claude.pichonnaz@hesav.ch

Claude Lessert, PT MSc contact

+41787746839

claudia.lessert@hesav.ch

Switzerland1 site
  • University Hospital of Lausanne CHUV

    Lausanne, Canton of Vaud, 1011

    Julien Wegrzyn, Professor, +4121 314 03 44, julien.wegrzyn@chuv.ch

Other trials in Switzerland

About this study

This study aims to evaluate the effectiveness of a digital patient education solution, CHUVeduc@home, in improving preoperative preparation for patients undergoing total hip or knee arthroplasty. In Switzerland, many patients receive joint replacements each year to relieve osteoarthritis-related pain. With shorter hospital stays, adequate preparation before surgery has become increasingly important.

A total of 160 patients will be randomized into two groups:

Read more

Intervention group: access to CHUVeduc@home before surgery. Control group: standard preoperative preparation (group information session and consultation).

All participants will complete questionnaires through the application. No additional visits are required. The intervention lasts approximately 12 weeks.

The primary goal is to determine whether digital education increases patient knowledge, confidence, and satisfaction, and facilitates recovery and return home after surgery. Participation is voluntary and can be withdrawn at any time.

Read the detailed description

Study Purpose:

The purpose of this study is to improve preparation for hip or knee surgery. Each year in Switzerland, a large number of individuals receive a hip or knee prosthesis to relieve pain caused by osteoarthritis. Through enhanced perioperative care programs such as the one implemented at CHUV, the length of hospital stay has decreased, making preoperative preparation increasingly important.

Current Practice:

Current practice includes participation in a group information session and a preoperative consultation. However, retaining all provided information can be challenging. To support more effective preparation, the investigators will evaluate a digital application called CHUVeduc@home, integrated within CHUV@home, which is already used during postoperative recovery.

Features of the Application:

The application provides the possibility to:

Review information at an individualized pace. Improve understanding of the surgical and recovery processes. Access quizzes and practical information sheets for training purposes.

Submit questions directly to the Telemonitoring Center team.

Study Design:

The study plans to include 160 participants. Participants will be randomly assigned to one of two groups:

A group using the application before surgery. A group following the usual preoperative preparation process.

All participants will use the application to complete study questionnaires. No additional appointments are required. The study duration is approximately 12 weeks. Participation is voluntary and can be discontinued at any time.

Expected Benefits:

The investigators anticipate that this digital approach to preoperative preparation may help participants feel more confident, better informed, and better supported during their return home after surgery.

Being tested
Digital Preoperative Education with CHUVeduc@home, Standard Care Pathway
Keywords
knee, hip, replacement, arthroplasty, patient education, digital solution, preoperative care, perioperative care, interdisciplinary intervention, physiotherapy, nursing, health literacy, digital literacy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Preoperative Education with CHUVeduc@homeBehavioural

    The intervention consists of a personalized digital education program delivered through the CHUVeduc@home mobile application, integrated within the existing CHUV@home platform. The application is available to patients 2 to 6 weeks prior to surgery and provides:

    • Educational modules covering postoperative recovery, pain management, rehabilitation, and discharge planning.
    • Quizzes and knowledge tests to reinforce patient understanding.
    • Practical advice sheets for concrete preparation.
    • Individualized pacing and guidance tailored to patient needs.
    • Notifications prompting completion of study questionnaires.

    The goal of the intervention is to improve patient health literacy, reduce preoperative anxiety, increase confidence, and facilitate recovery and return home after total hip or knee arthroplasty.

  • Standard Care PathwayBehavioural

    The main steps include:

    • Consultation with the surgeon
    • Group information session
    • Preoperative consultation
    • Hospital stay for surgery
    • Discharge and return home
    • Telemonitoring with CHUV@home after surgery
    • Postoperative follow-up visit at 6 weeks

    Participants in this group also use the CHUV@home application to complete study-specific questionnaires; however, they do not receive any additional educational content prior to surgery.

Study groups in NCT07345299
Study groupRoleWhat they receive
Intervention Group: access to CHUVeduc@home before surgeryExperimentalIntervention Group - Pathway with CHUVeduc@home This group follows the standard preoperative pathway, complemented by personalized digital preparation through the CHUVeduc@home application, available 2 to 6 weeks before surgery.
Receives: Behavioral: Digital Preoperative Education with CHUVeduc@home
Control Group - Standard Care PathwayActive comparatorControl Group - Standard Care Pathway This group follows the standard clinical care pathway established at CHUV for patients undergoing total hip or knee arthroplasty. The main steps include: * Consultation with the surgeon * Group information session * Preoperative consultation * Hospital stay for surgery * Discharge and return home * Telemonitoring with CHUV@home after surgery * Postoperative follow-up visit at 6 weeks Participants in this group also use the CHUV@home application to complete study-specific questionnaires; however, they do not receive any additional educational content prior to surgery.
Receives: Behavioral: Standard Care Pathway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patient calls to the remote care center (CTS)

    The primary outcome is the total number of calls initiated by patients to the remote care support center (CTS) during the intervention period. This measure will assess the impact of the digital education tool on patient autonomy and the need for additional support. A lower number of calls is expected to reflect improved patient preparation and self-management.

    Measured: During the intervention period (from inclusion until surgery, up to 6 weeks)

  2. Reason for contacts, the severity of alerts

    This secondary objective aims to analyze the specific reasons for patient contacts, assess the severity of alerts generated, and evaluate the potential financial benefits associated with a decrease in the number of contacts, thereby providing a comprehensive understanding of the impact of the telemonitoring intervention.

    Measured: During the intervention period (from inclusion until surgery, up to 6 weeks)

Secondary outcomes (15)
  1. Patient-reported health status and quality of life (EQ-5D-5L)

    Generic health-related quality-of-life measure including five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and a visual analogue scale (VAS).

    Range:

    Index score: typically ranges from <0 (health states worse than death) to 1 (perfect health).

    VAS: 0 to 100, where 100 indicates the best imaginable health.

    Direction: Higher scores reflect better health status.

    Measured: At preadmission (3 days before surgery), and 6 weeks postoperatively

  2. Patient satisfaction (ANQ questionnaire)

    Patient satisfaction with hospital care will be evaluated using the Association Nationale pour la Qualité (ANQ) patient satisfaction questionnaire.

    The ANQ questionnaire includes multiple items each rated on a Likert scale from 1 to 5, where higher scores indicate greater satisfaction. Depending on the domain structure used locally, total scores typically range from 1 (lowest satisfaction) to 5 (highest satisfaction) per item; domain or global scores are expressed as mean values, with higher values reflecting better satisfaction with care.

    Measured: 1 week after hospital discharge

  3. Patient engagement (Patient Activation Measure [PAM-13]

    Patient engagement in disease management and surgical preparation will be assessed using the Patient Activation Measure-13 (PAM-13).

    The PAM-13 contains 13 items, each scored from 1 (strongly disagree) to 4 (strongly agree).

    Raw scores are converted to a standardized activation score ranging from 0 to 100.

    Higher scores indicate greater patient activation, confidence, and involvement in their own health management.

    Scores classify patients into four activation levels, with Level 1 = lowest activation and Level 4 = highest activation.

    Measured: At baseline during the intervention period , at preadmission (3 days before surgery) and 6 weeks postoperatively

  4. Physical activity (International Physical Activity Questionnaire [IPAQ])

    Physical activity levels will be assessed using the International Physical Activity Questionnaire (IPAQ - Short Form).

    The IPAQ evaluates physical activity performed in the last 7 days across four domains: walking, moderate-intensity activity, vigorous-intensity activity, and sedentary time.

    Scores are expressed as Metabolic Equivalent of Task (MET)-minutes per week. Total physical activity score typically ranges from 0 MET-min/week (no reported activity) to > 3,000 MET-min/week (very high activity levels).

    Higher MET-min/week scores indicate higher levels of physical activity.

    Participants will also be classified into the IPAQ categories:

    Low physical activity, Moderate physical activity, High physical activity, based on standard IPAQ scoring guidelines.

    Measured: At baseline during the intervention period and 6 weeks postoperatively

  5. Fear and anxiety related to surgery (Survey of Surgical Fear [SSF])

    Fear and anxiety associated with the upcoming surgery will be measured using the Survey of Surgical Fear (SSF).

    The SSF includes 8 items, each rated from 0 (not at all fearful) to 10 (extremely fearful).

    Total score range: 0 to 80.

    The questionnaire provides two subscale scores:

    • Short-term surgical fear (items 1-4), range 0-40
    • Long-term surgical fear (items 5-8), range 0-40

    Higher scores indicate higher levels of fear and anxiety related to surgery.

    Measured: At baseline during the intervention period and at preadmission (3 days before surgery)

  6. Pain (Numeric Rating Scale for pain)

    Patients will report pain intensity using the Numeric Rating Scale (EVA), during routine follow-up visits.

    Measured: At hospital discharge (Day 3-5) and at 6 weeks postoperatively

  7. Patients' expectations regarding surgery outcomes (Hospital for Special Surgery Knee/Hip Expectations Survey [HSS Knee or Hip])

    Patient expectations concerning pain relief, mobility, essential daily activities, psychological benefits, and non-essential activities (e.g., sport/leisure) will be measured using the Hospital for Special Surgery (HSS) Knee or Hip Expectations Survey, depending on the type of surgery.

    Measured: At baseline (prior to surgery) during the intervention period

  8. Qualitative analysis of patient messages to the remote care team (CTS)

    A qualitative review of the messages sent by patients to the remote care support team (CTS) will be performed to identify difficulties encountered during the intervention and the solutions provided.

    Measured: During the intervention period (from inclusion until surgery, up to 12 weeks)

  9. Patient-reported Oxford Knee Score [OKS] or Oxford Hip Score [OHS])

    Joint-specific questionnaire assessing knee or hip pain and functional ability after knee or hip surgery.

    Range: 0 to 48, based on 12 items (0-4 per item).

    Direction: Higher scores indicate better knee or hip function and less pain.

    Measured: At preadmission (3 days before surgery) and 6 weeks postoperatively

  10. Patient satisfaction with mobile application (uMARS scale)

    Satisfaction with the mobile application will be assessed using the User Version of the Mobile Application Rating Scale (uMARS).

    The uMARS consists of 20 items rated from 1 to 5, grouped into four objective quality subscales (engagement, functionality, aesthetics, information) and one subjective quality subscale. Subscale and total scores range from 1 (poor quality) to 5 (excellent quality). Higher uMARS scores reflect greater perceived app quality and satisfaction.

    Measured: At preadmission (3 days before surgery)

  11. Health literacy, French eHealth Literacy Scale [F-eHEALS])

    Health literacy will be evaluated using the French version of the eHealth Literacy Scale (F-eHEALS).

    The F-eHEALS contains 8 items, each rated from 1 (strongly disagree) to 5 (strongly agree).

    Total score range: 8 to 40. Higher scores indicate better perceived eHealth literacy, including ability to find, appraise, and use online health information.

    Measured: At baseline during the intervention period and 6 weeks postoperatively

  12. Postoperative complications (clinical assessment)

    Postoperative complications will be recorded by clinical staff according to routine medical documentation.

    Outcomes include the presence or absence of complications and the type of complication (e.g., infection, thromboembolic event, wound complication, cardiovascular or respiratory event).

    This is a categorical clinical outcome (no scoring scale).

    Measured: At hospital discharge (Day 3-5) and at 6 weeks postoperatively

  13. Length of stay (days of hospitalization)

    Length of hospital stay, expressed in days, with higher values indicating longer hospitalization.

    Measured: At hospital discharge

  14. Hospital readmission (yes/no)

    Hospital readmissions within the follow-up period will be recorded by clinical staff.

    Reported as yes/no, with reason for readmission documented when applicable. This is a binary clinical outcome (no scoring scale).

    Measured: At 6 weeks postoperatively

  15. Stratified analysis of intervention effectiveness by patient characteristics

    A stratified analysis will be conducted to evaluate whether the impact of the digital education intervention varies across patient subgroups (e.g., age, education level, comorbidity profile). This will help identify clusters of patients who benefit most from digital education.

    Measured: At the end of the intervention period (up to 12 weeks after inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2026
  2. Study start15 Feb 2026 (estimated)
  3. Primary completion28 Feb 2027 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Clinical Trial
Masking
None (open label)
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07345299
Sponsor's protocol ID
CHUVeduc@home
Acronym
CHUVeduc@home
Status last verified
Jan 2026
First submitted
29 Aug 2025
Last updated
15 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Agri F, Hahnloser D, Demartines N, Hubner M. Gains and limitations of a connected tracking solution in the perioperative follow-up of colorectal surgery patients. Colorectal Dis. 2020 Aug;22(8):959-966. doi: 10.1111/codi.14998. Epub 2020 Feb 27.

    PubMed 32012423
  • Roulin D, Blanc C, Demartines N, Hubner M. [Enhanced Recovery After Surgery--optimal management of the surgical patient]. Rev Med Suisse. 2014 Jun 18;10(435):1343-7. French.

    PubMed 25051597
  • Ljungqvist O, Hubner M. Enhanced recovery after surgery-ERAS-principles, practice and feasibility in the elderly. Aging Clin Exp Res. 2018 Mar;30(3):249-252. doi: 10.1007/s40520-018-0905-1. Epub 2018 Feb 16.

    PubMed 29453605
  • Stoyanov SR, Hides L, Kavanagh DJ, Wilson H. Development and Validation of the User Version of the Mobile Application Rating Scale (uMARS). JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72. doi: 10.2196/mhealth.5849.

    PubMed 27287964
  • Wainwright TW, Gill M, McDonald DA, Middleton RG, Reed M, Sahota O, Yates P, Ljungqvist O. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Acta Orthop. 2020 Feb;91(1):3-19. doi: 10.1080/17453674.2019.1683790. Epub 2019 Oct 30.

    PubMed 31663402

Questions about this trial

What is this clinical trial studying?

A study testing Digital Preoperative Education with CHUVeduc@home in people with Arthroplasty Replacement, Knee and Arthroplasty, Replacement, Hip, run by Haute Ecole de Santé Vaud at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Claude Pichonnaz, Ph.D (+41213168126, claude.pichonnaz@hesav.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patient calls to the remote care center (CTS) (time frame: During the intervention period (from inclusion until surgery, up to 6 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07345299, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in